20-[18F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: Synthesis and tissue distribution studies

A. Liu, J. A. Katzenellenbogen, H. F. VanBrocklin, C. J. Mathias, M. J. Welch

Research output: Contribution to journalArticlepeer-review

Abstract

To develop an androgen receptor-based, positron-emitting imaging agent for prostate tumors, we have prepared 20-fluoromibolerone (F-Mib) and evaluated its tissue distribution. This compound was synthesized in eight steps from 7α-methyl-19-nortestosterone, with fluorine introduced in the penultimate step by fluoride ion displacement on a spirocyclic sulfate. Fluoromibolerone was obtained in 9%-19% radiochemical yield (decay corrected), at 1.5 hr after bombardment, with an effective specific activity of 217-283 Ci/mmol. The relative binding affinity of F-Mib is 53 (versus R1881 = 100 or mibolerone = 118). In tissue distribution studies in diethylstilbestrol-treated male rats, 18F-Mib demonstrates high target/tissue uptake efficiency and selectivity: the prostate uptake at 0.5 hr and 4 hr is 1.0%-1.3% injected dose/gram tissue (ID/g) and 0.5%-0.6% ID/g, respectively; the prostate-to-blood and the prostate-to-muscle (non-target) ratios are both ca. 4 at 0.5 hr, and increase to ca. 12 by 4 hr after injection. The observed distribution of 18F-Mib suggests that it may be useful for in vivo imaging of prostatic tumors in man by positron emission tomography.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalJournal of Nuclear Medicine
Volume32
Issue number1
StatePublished - 1991

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of '20-[<sup>18</sup>F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: Synthesis and tissue distribution studies'. Together they form a unique fingerprint.

Cite this